Latest News

MRI-guided TULSA effective for managing localized prostate cancer
MRI-guided TULSA effective for managing localized prostate cancer

December 2nd 2023

“Our experience with TULSA demonstrates substantial post-procedure decreases in PSA level, PSA density, and prostate volume,” the researchers wrote.

Small mpMRI index lesions are favorable marker for guiding active surveillance strategies
Small mpMRI index lesions are favorable marker for guiding active surveillance strategies

December 1st 2023

Urine-based test demonstrates consistent efficacy in NMIBC surveillance
Urine-based test demonstrates consistent efficacy in NMIBC surveillance

December 1st 2023

3d rendered illustration of bladder cancer | Image Credit: © SciePro - stock.adobe.com
Blue light cystoscopy significantly decreases risk of recurrence in NMIBC

December 1st 2023

Nadofaragene firadenovec efficacy in NMIBC sustained with extended follow-up
Nadofaragene firadenovec efficacy in NMIBC sustained with extended follow-up

December 1st 2023

Latest Videos

Latest News

© 2023 MJH Life Sciences

All rights reserved.